SUBSTITUIERTE PHENYLPROPIONSÄUREDERIVATE ALS AGONISTEN DES MENSCHLICHEN PEROXISOM-PROLIFERATOR-AKTIVERTEN REZEPTORS ALPHA(PPAR)

摘要

The present invention provides the S enantiomer of a compound of formula (I) wherein n is 1 or 2 as well as pharmaceutically acceptable salts, solvates, crystalline forms and prodrugs thereof, to processes for preparing such compounds, to their utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.